Ò©ÀíѧÂÛÎÄ

Äúµ±Ç°µÄλÖãºÑ§ÊõÌà > ҽѧÂÛÎÄ > »ù´¡Ò½Ñ§ÂÛÎÄ > Ò©ÀíѧÂÛÎÄ >

ijҽԺסԺ»¼ÕßʹÓðÂÇúëĵĺÏÀíÐÔ̽¾¿

À´Ô´£ºÖйúÒ©Òµ ×÷Õߣº³ÌÍôÇÚ.
·¢²¼ÓÚ£º2021-08-13 ¹²4331×Ö

¡¡¡¡Õª    Òª£º¡¡Ä¿µÄ ̽ÌÖ°ÂÇúëÄÁÙ´²Ó¦ÓõĺÏÀíÐÔ¡£·½·¨ Ñ¡È¡Ò½Ôº2019Äê9ÔÂÖÁ12ÔÂʹÓðÂÇúëĵÄסԺ»¼ÕߵIJ¡Àú70·Ý£¬Í³¼Æ°ÂÇúëĵÄÓÃÒ©ÊÊÓ¦Ö¤¡¢Ó÷¨ÓÃÁ¿¡¢ÓÃÒ©ÁƳ̡¢ÁªºÏÓÃÒ©¡¢Ò©Æ·²»Á¼·´Ó¦(ADR)µÈÇé¿ö£¬²¢·ÖÎöÓÃÒ©ºÏÀíÐÔ¡£½á¹û ËùÑ¡²¡ÀúÖаÂÇúëĵÄÓÃÒ©ÊÊÓ¦Ö¤ÒÔÏû»¯µÀ³öѪ¡¢¼±ÐÔÒÈÏÙÑס¢³¦¹£×èΪÖ÷£¬¼ÁÁ¿Îª0.1¡«0.8 mg/d£¬ÁƳÌΪ1¡«15 d£¬Ö÷ÒªÓëÖÊ×Ó±ÃÒÖÖƼÁ(42Àý)ÁªÓÃ;ÓÃÒ©ÆÚ¼äδ³öÏÖADR¡£²»¹æ·¶¡¢²»ºÏÀíÓÃÒ©¹²7Àý£¬Ö÷ҪΪÎÞÖ¸Õ÷ÓÃÒ©¡¢ÓÃÒ©ÁƳ̲»ÊÊÒ˵ȡ£½áÂÛ ¸ÃÔº°ÂÇúëĵÄÁÙ´²Ó¦ÓôæÔÚÒ»¶¨²»ºÏÀíÐÔ£¬Ðè³ÖÐø¸Ä½ø¡£

¡¡¡¡¹Ø¼ü´Ê :     °ÂÇúëÄ;ÁÙ´²Ó¦ÓÃ;ÓÃÒ©·ÖÎö;ºÏÀíÓÃÒ©;

¡¡¡¡Abstract£º¡¡Objective To investigate the rationality of the clinical application of octreotide. Methods A total of 70 medical records of inpatients treated with octreotide in our hospital from September to December 2019 were selected. The indications,usage and dosage,course of treatment,combination medication and adverse drug reactions( ADR) of octreotide were analyzed,and the rationality of medication was analyzed. Results The medication indications of octreotide were gastrointestinal bleeding,acute pancreatitis and intestinal obstruction. The dosage of octreotide was 0. 1-0. 8 mg/d with a treatment course of 1-15 d,mainly combined with proton pump inhibitors( 42 cases). There was no ADR during the medication. There were 7 cases of irregular and irrational medication,mainly including medication without indication and inappropriate treatment course. Conclusion The clinical application of octreotide in our hospital is unreasonable and needs continuous improvement.

¡¡¡¡Keyword£º¡¡octreotide; clinical application; medication analysis; rational medication;

¡¡¡¡°ÂÇúëÄΪÈ˹¤ºÏ³ÉµÄÌìÈ»Éú³¤ÒÖËصİËëÄ»·×´»¯ºÏÎ¾ßÓÐÒÖÖÆÉú³¤¼¤ËØ¡¢´Ù¼××´ÏÙËØ¡¢Î¸³¦µÀºÍÒÈÄÚ·ÖÃÚ¼¤Ëز¡ÀíÐÔ·ÖÃÚ¹ý¶à£¬ÒÖÖÆÒÈø¡¢ÒȸßѪÌÇËغÍÒȵºËØ·ÖÃڵȶàÖÖÉúÀí»îÐÔ£¬ÒÖÖÆθËᡢθµ°°×øºÍθÃÚËØ·ÖÃÚ£¬¸ÄÉÆθð¤Ä¤ÑªÁ÷¹©Ó¦£¬´Ù½øð¤Ä¤µÄÐÞ¸´£¬ÁÙ´²ÓÃÓÚÖÎÁÆÓ¦¼¤ÐÔÀ£ÑñºÍÏû»¯ÐÔÀ£ÑñÒýÆðµÄ賦µÀ´ó³öѪ[1]¡£°ÂÇúëĵÄÁÙ´²ÊÊÓ¦Ö¤¹ã£¬Îª´Ù½øÁÙ´²¹æ·¶¡¢ºÏÀíÓ¦Ó㬱¾Ñо¿ÖлعËÐÔ·ÖÎöÁËÎÒԺסԺ»¼Õß°ÂÇúëĵÄʹÓÃÇé¿ö£¬ÎªÁÙ´²ºÏÀíÓÃÒ©Ìṩ²Î¿¼¡£ÏÖ±¨µÀÈçÏ¡£

¡¡¡¡1 ¡¢×ÊÁÏÓë·½·¨

¡¡¡¡Ëæ»úÑ¡È¡ÎÒÔºÒ½ÔºÐÅϢϵͳÖÐ2019Äê9ÔÂÖÁ12ÔÂʹÓðÂÇúëĵÄסԺ»¼ÕߵIJ¡Àú70·Ý£¬²ÎÕÕ°ÂÇúëÄҩƷ˵Ã÷Êé¡¢¡¶³ÂÐÂǫбàÒ©Îïѧ(µÚ18°æ)¡·[1]¡¢Ïà¹ØÖ¸ÄÏÓëÎÄÏ×Öƶ©°ÂÇúëÄÁÙ´²Ó¦Óõ÷²é±í¡£µ÷²é±íÄÚÈÝ°üÀ¨»¼Õß»ù±¾ÐÅÏ¢¡¢ÓÃÒ©ÊÊÓ¦Ö¤¡¢Ó÷¨ÓÃÁ¿¡¢ÓÃÒ©ÁƳ̡¢ÁªºÏÓÃÒ©¡¢Ò©Æ·²»Á¼·´Ó¦(ADR)µÈÐÅÏ¢£¬ÒÔÆÀ¼Û°ÂÇúëÄÁÙ´²Ó¦ÓõĺÏÀíÐÔ¡£

1.png

¡¡¡¡2¡¢ ½á¹û

¡¡¡¡2.1¡¢ »¼Õß»ù±¾ÐÅÏ¢

¡¡¡¡70Àý»¼ÕßÖУ¬ÄêÁä15¡«88Ë꣬ƽ¾ù62Ëê;ÄÐ47Àý£¬Å®23Àý;¹²ÓÐ9¸öÁÙ´²¿ÆÊÒʹÓðÂÇúëÄ£¬ÆäÖÐÏû»¯ÄÚ¿Æ30Àý£¬Î¸³¦Íâ¿Æ17Àý¡£Ïê¼û±í1¡£

¡¡¡¡±í1 70·Ý²¡ÀúÖÐʹÓðÂÇúëĵÄÁÙ´²¿ÆÊÒ¼°»¼ÕßÐÔ±ðÇé¿ö

GetImg (1).jpg

¡¡¡¡2.2 ¡¢ÊÊÓ¦Ö¤

¡¡¡¡70Àý»¼ÕßÖУ¬¹²Éæ¼°12ÖÖÓÃÒ©Ö¸Õ÷£¬°üÀ¨Ïû»¯µÀ³öѪ31Àý¡¢¼±ÐÔÒÈÏÙÑ×15Àý¡¢³¦¹£×è16ÀýµÈ¡£ÆäÖУ¬·ûºÏÓÃÒ©Ö¸Õ÷17Àý(24.29%)£¬³¬Ò©Æ·ËµÃ÷ÊéÓÃÒ©46Àý(65.71%)¡£²»¹æ·¶¡¢²»ºÏÀíÓÃÒ©7Àý(10.00%)£¬Ö÷ҪΪÎÞÖ¸Õ÷ÓÃÒ©¡¢ÓÃÒ©ÁƳ̲»ÊÊÒ˵ȡ£Ïê¼û±í2¡£

¡¡¡¡2.3 ¡¢Ó÷¨ÓÃÁ¿

¡¡¡¡70Àý»¼ÕßÖУ¬³ÖÐø¾²Âö±Ã×¢44Àý£¬Æ¤ÏÂ×¢Éä26Àý£¬ÈܼÁ¾ùΪ0.9%ÂÈ»¯ÄÆ×¢ÉäÒº;²»Í¬ÓÃÒ©Ö¸Õ÷µÄÓÃÁ¿ÓвîÒ죬0.1 mg/d 1Àý£¬0.3 mg/d 31Àý£¬0.45 mg/d 7Àý£¬0.6 mg/d 30Àý£¬0.8 mg/d 1Àý;ÓÃÒ©ÁƳÌΪ1¡«15 d£¬ÒÔ¸¹Í´ºÍ¸¹ÕÍ»º½â¡¢¿É½øʳÁ÷ÖÊÒûʳ¡¢Î¸³¦µÀÖ¢×´¸ÄÉƼ°ºÃתΪͣҩָÕ÷¡£Ïê¼û±í2¡£

¡¡¡¡2.4¡¢ ÁªºÏÓÃÒ©ÓëADR

¡¡¡¡70Àý»¼ÕßÖУ¬ÁªÓÃÖÊ×Ó±ÃÒÖÖƼÁ42Àý(60.00%)¡£ÆäÖУ¬ÁªºÏÓÃÓÚÏû»¯µÀ³öѪ27Àý(38.57%)£¬¼±ÐÔÒÈÏÙÑ×8Àý(11.43%)£¬³¦¹£×è7Àý(10.00%)¡£ÓÃÒ©ÆÚ¼ä¾ùδ·¢ÏÖADR¡£

¡¡¡¡3 ¡¢ÌÖÂÛ

¡¡¡¡3.1 ¡¢³¬Ò©Æ·ËµÃ÷ÊéÓÃÒ©ºÍÎÞÖ¸Õ÷ÓÃÒ©ÏÖÏóÃ÷ÏÔ

¡¡¡¡°ÂÇúëÄ×¢ÉäҺҩƷ˵Ã÷ÊéÅú×¼µÄÊÊÓ¦Ö¤°üÀ¨¸ÎÓ²»¯ËùÖÂʳµÀθµ×¾²ÂöÇúÕųöѪµÄ½ô¼±ÖÎÁÆ£¬»º½âÓë賦ÒÈÄÚ·ÖÃÚÖ×ÁöÓйصÄÖ¢×´ÓëÌåÕ÷£¬Ô¤·ÀÒÈÏÙÊõºó²¢·¢Ö¢ºÍÖ«¶Ë·Ê´óÖ¢¡£±¾Ñо¿ÖУ¬½ö17Àý»¼ÕßµÄÊÊÓ¦Ö¤·ûºÏ°ÂÇúëĵÄÓÃÒ©ÊÊÓ¦Ö¤£¬46Àý³¬Ò©Æ·ËµÃ÷ÊéÓÃÓÚ¼±ÐÔÒÈÏÙÑס¢³¦¹£×èµÈ¼²²¡µÄ·ÀÖΡ£

¡¡¡¡±í2 »¼ÕßÓÃÒ©Ö¸Õ÷¼°Ó÷¨ÓÃÁ¿(n=70)

GetImg (2).jpg

¡¡¡¡Ïû»¯µÀ³öѪÊÇÏû»¯µÀÖ×ÁöµÄÖ÷ÒªÁÙ´²±íÏÖ»òÊ×·¢Ö¢×´¡£¾²ÂöµÎ×¢Éú³¤ÒÖËؼ°ÀàËÆÎïÁªºÏÖÊ×Ó±ÃÒÖÖƼÁ¶ÔÖ×ÁöÐÔ³öѪºÍ¼±ÐÔθð¤Ä¤ËðÉËÓÐЧ[2];¶ÔÓÚ²»Ã÷Ô­Òò¼±ÐÔÏû»¯µÀ³öѪ£¬¿É¾²Âö±Ã×¢ÖÊ×Ó±ÃÒÖÖƼÁÁªÓÃÉú³¤ÒÖËØ»òÆäÀàËÆÎïÖÎÁÆ£¬²¡ÒòÃ÷È·ºóÔÙµ÷ÕûÓÃÒ©[3]¡£ÄÚ¾µÏÂÖÎÁÆ»òÍâ¿ÆÖÎÁÆÎÞЧµÄÒòÏû»¯µÀѪ¹Ü·¢Óý²»Á¼¶ø³öѪ»¼ÕßʹÓðÂÇúëÄÖÎÁÆ£¬¿É½µµÍÊäѪƵÂÊ£¬ÇÒÖÎÁÆÄÑÖÎÐÔС³¦Ñª¹Ü·¢Óý²»Á¼³öѪÁÆЧ½ÏºÃ[4]¡£±¾Ñо¿ÖаÂÇúëÄÓÃÓÚʳ¹Üθµ×¾²ÂöÇúÕÅÆÆÁѳöѪ13Àý£¬Ïû»¯ÐÔÀ£Ññ°é³öѪ6Àý£¬¶ñÐÔÖ×Áö°éÏû»¯µÀ³öѪ8Àý£¬²»Ã÷Ô­ÒòÏû»¯µÀ³öѪ4Àý£¬¸øÒ©ºó³öѪ֢״¾ùºÃת£¬ÎÞÑÏÖز¢·¢Ö¢¡£

¡¡¡¡¡¶Öйú¼±ÐÔÒÈÏÙÑ×ÕïÖÎÖ¸ÄÏ(2019ÉòÑô)¡·Ö¸³ö£¬°ÂÇúëÄ¿Éͨ¹ýÖ±½ÓÒÖÖÆÒÈÏÙÍâ·ÖÃÚ¶ø·¢»Ó×÷Ó㬶ÔÔ¤·ÀERCPÊõºóÒÈÏÙÑ×Ò²Óлý¼«×÷ÓÃ[5]¡£°ÂÇúëĸ¨Öú³£¹æÖÎÁÆÇáÐÍ/ÖØÖ¢¼±ÐÔÒÈÏÙÑ×£¬ÁÙ´²ÁÆЧºÃ£¬¿ÉÏÔןÄÉÆѪҺÁ÷±äѧָ±ê¼°ÑªÇåÑ×ÐÔÒò×Óˮƽ£¬ÓÐЧ½µµÍѪÇåµí·Ûøˮƽ£¬¸ÄÉÆÔ¤ºó£¬¼õÉÙ²¢·¢Ö¢[6,7]¡£±¾Ñо¿ÖУ¬°ÂÇúëÄÓÃÓÚ¼±ÐÔÒÈÏÙÑ×15Àý£¬ÆäÖÐÖÐÖضÈÒÈÏÙÑ×10Àý¡¢ÇáÖ¢ÒÈÏÙÑ×5Àý£¬ÁÙ´²¾ùÔçÆÚÓ¦ÓðÂÇúëÄÒÖÖÆÒÈø·ÖÃÚ£¬¸¹Í´Ã÷ÏÔ»º½â£¬Ñ×ÐÔÖ¸±ê¸ÄÉÆ£¬ÌáʾÖÎÁÆÓÐЧ¡£

¡¡¡¡³¦¹£×èÊÇÒ»ÖֱȽÏÆÕ±éµÄ¼±¸¹Ö¢£¬°ÂÇúëÄ¿Éͨ¹ý¼õÉÙ賦µÀÏÙÌå·ÖÃÚ¼°ÄÚÔàѪÁ÷Á¿£¬¼õÇ᳦¹£×軼Õߵĸ¹ÕÍ¡¢¸¹Í´Ö¢×´£¬ÓÐЧ¸ÄÉÆ賦µÀ¹¦ÄÜ£¬ÓÅÓÚ¿¹µ¨¼îÀàÒ©ÎÁªºÏ³£¹æÖÎÁÆÓÃÓÚ³¦¹£×è¿ÉÌá¸ßÁÆЧ¡¢¸ÄÉÆÖ¢×´£¬¼õÉÙ²»Á¼·´Ó¦[8,9,10]¡£±¾Ñо¿ÖУ¬°ÂÇúëÄÓÃÓÚ³¦¹£×è16Àý£¬ÆäÖÐ賦µÀÖ×ÁöÊõºó°é³¦¹£×è8Àý£¬ÓÃÒ©ºó£¬¸¹Í´¡¢¸¹ÕÍÖ¢×´¾ùÃ÷ÏÔ»º½â£¬¸¹²¿Ñ¹Í´·¶Î§ËõС£¬¸ØÃŻָ´ÅÅÆøÅű㣬ÇÒδ¼û°ÂÇúëÄÏà¹ØADR¡£

¡¡¡¡²ÎÕÕ°ÂÇúëÄҩƷ˵Ã÷Êé¡¢¹úÄÚÍâÁÙ´²Ö¸Äϼ°Ïà¹ØÎÄÏ×£¬ÎÞÖ¸Õ÷ÓÃÒ©3Àý¡£1ÀýÕï¶ÏΪ¸ÎÓ²»¯¡¢Æ¢´óµÄ»¼Õߣ¬Ðв¿·ÖÆ¢¶¯Âö˨ÈûÖÎÁÆ£¬ÊõºóÎÞÃ÷ÏÔ²»ÊÊ£¬¸øÓè°ÂÇúëÄÒÖËáÖÎÁÆ£¬ÎÞÃ÷È·ÓÃÒ©Ö¸Õ÷;ÁíÓÐ2Àý賦µÀÖ×Áö»¼ÕßÎÞ¶ñÐÄŻ͡¢¸¹ÐººÚ±ãµÈ£¬ÁÙ´²Ó¦ÓðÂÇúëÄ´Ù½ø³¦µÀÈ䶯£¬Ô¤·À³¦¹£×èµÄ·¢Éú£¬ÎÞÃ÷È·ÓÃÒ©Ö¸Õ÷¡£

¡¡¡¡3.2¡¢ Ó÷¨ÓÃÁ¿Ó¦·ûºÏҩƷ˵Ã÷ÊéÍƼö

¡¡¡¡°ÂÇúëij£Óøøҩ;¾¶ÓÐÖ±½Ó¾²ÂöµÎ×¢¡¢Æ¤ÏÂ×¢É估΢Á¿ÊäÒº±Ã¾²ÂöµÎ×¢¡£±¾Ñо¿ÖУ¬³ÖÐø¾²Âö±Ã×¢44Àý£¬Æ¤ÏÂ×¢Éä26Àý¡£²»Í¬¸øÒ©·½Ê½È¡µÃµÄÁÆЧ²»Í¬£¬³ÖÐø΢Á¿ÊäÒº±Ã²»½öÄܵ÷½Ú¸øÒ©Ëٶȣ¬ÓÃÒ©¼ÁÁ¿¸ü¾«×¼£¬ÔÚ±£Ö¤ÑªÒ©Å¨¶ÈµÄͬʱ£¬»¹ÄܼõÉÙ¸øÒ©´ÎÊý;ÄÜÔÚ¶Ìʱ¼äÄÚÓÐЧ¿ØÖÆʳ¹Üθµ×¾²ÂöÇúÕÅÆÆÁѳöѪ֢״£¬ÖÎÁƼ±ÐÔÒÈÏÙÑס¢³¦¹£×èÓÅÊÆÃ÷ÏÔ[11]¡£Ò©Æ·ËµÃ÷ÊéÍƼö°ÂÇúëĵijõʼ¼ÁÁ¿Îª0.05¡«0.10 mg/d£¬×î´ó¼ÁÁ¿²»³¬¹ý1.5 mg/d£¬Ò»°ã¼ÁÁ¿·¶Î§Îª0.05¡«1.20 mg/d£¬±¾Ñо¿°ÂÇúëĵÄÓÃÒ©¼ÁÁ¿·¶Î§Îª0.1¡«0.8 mg/d£¬ÓëҩƷ˵Ã÷ÊéÍƼö¼ÁÁ¿·¶Î§Ò»Ö¡£

¡¡¡¡3.3 ¡¢ÁƳ̲»Ò»

¡¡¡¡°ÂÇúëÄÓÃÓÚʳ¹Üθ¾²ÂöÇúÕÅÆÆÁѳöѪ¡¢Î¸³¦ÒÈÄÚ·ÖÃÚÖ×Áö¡¢Ô¤·ÀÒÈÏÙÊõºó²¢·¢Ö¢¡¢Ö«¶Ë·Ê´óÖ¢µÈÊÊÓ¦Ö¤¾ùÓÐÃ÷È·µÄÁƳ̣¬ÆäÓà¾ùÒÔÁÙ´²Ö¢×´ºÃת×÷Ϊͣҩָ±ê¡£¿É¼û£¬°ÂÇúëĵÄÓÃÒ©ÁƳ̲»Ò»¡£¼±ÐÔÒÈÏÙÑ×»¼ÕßÖ±µ½ÁÙ´²Ö¢×´Ïûʧ¡¢ÑªÄòµí·Ûø»Ö¸´Õý³£Ë®Æ½²ÅÍ£Óã¬Ò»°ãΪ10 d[12]¡£±¾Ñо¿ÖУ¬15Àý¼±ÐÔÒÈÏÙÑ×ÖУ¬5ÀýÁƳÌ1¡«3 d,6Àý4¡«7 d,3Àý8¡«9 d,1Àý15 d£¬ÓÃÒ©ÁƳÌÓëÎÄÏ×[10]µÄ±¨µÀ»ù±¾Ïà·û;13ÀýÏû»¯µÀ³öѪÖУ¬11ÀýÓÃÒ©ÁƳ̲»³¬¹ý5 d£¬ÁƳ̹淶£¬2Àý³öѪ»¼Õߣ¬ÁƳÌΪ7 d£¬ÁƳÌÆ«³¤£¬µ«»¼Õß³öѪÁ¿½Ï´ó£¬¼Ì·¢Ê§ÑªÐÔÐÝ¿Ë£¬¿É×ÃÇéÑÓ³¤ÁƳÌ;3ÀýÓÃÓÚÔ¤·ÀERCPÊõºó²¢·¢Ö¢ÖУ¬½öÊ×´ÎƤÏÂ×¢Éä0.1 mg£¬ÊõºóʹÓÃ1¡«3 d£¬µ«ÆäÓÃÓÚÔ¤·ÀÒÈÏÙÊõºó²¢·¢Ö¢Ê±ÒªÇó³ÖÐøÖÎÁÆ7 d£¬ÁƳÌÃ÷ÏÔ²»×ã;1ÀýθÀ£Ññ°éÏû»¯µÀ³öѪÖУ¬Êõºó»Ö¸´Á¼ºÃ£¬ÎÞ¸¹Í´¡¢Å»Ñª¡¢±ãѪ£¬Ö¹Ñªºó¼ÌÐøʹÓã¬ÓÃÒ©ÁƳÌΪ9 d£¬ÁƳÌÆ«³¤¡£ÁƳ̹ý¶Ì´ï²»µ½ÖÎÁÆЧ¹û£¬ÁƳ̹ý³¤¿ÉÄÜ»áÔö¼ÓADRµÄ·¢Éú·çÏÕ¡£

¡¡¡¡3.4 ¡¢ÁªºÏÓÃÒ©¼°°²È«ÐÔ·ÖÎö

¡¡¡¡°ÂÇúëij£ÁªºÏÖÊ×Ó±ÃÒÖÖƼÁÓÃÓÚÏû»¯µÀ³öѪ¡¢¼±ÐÔÒÈÏÙÑס¢Õ³Á¬ÐÔ³¦¹£×èµÈÏû»¯ÏµÍ³Ïà¹Ø¼²²¡¡£Meta·ÖÎö±íÃ÷£¬°ÂÇúëÄÁªºÏÖÊ×Ó±ÃÒÖÖƼÁÖÎÁÆÉÏÏû»¯µÀ³öѪЧ¹ûÓÅÓÚµ¥ÓÃÖÊ×Ó±ÃÒÖÖƼÁ£¬Äܸü¿ì¡¢¸üÓÐЧµØֹѪ[13]£¬°²È«ÐÔºÃ[14]¡£±¾Ñо¿ÖУ¬42Àý»¼ÕßÁªÓÃÁËÖÊ×Ó±ÃÒÖÖƼÁ£¬¸¹Í´¡¢¸¹Õ͸ÐÃ÷ÏÔ»º½â£¬Î´Å»Ñª¡¢ºÚ±ã£¬²¡ÇéºÃת¡£

¡¡¡¡ÓйذÂÇúëÄADR±¨µÀ½ÏÉÙ£¬Ö÷ÒªADRΪÓÃÒ©²¿Î»²»ÊʺÍ賦µÀ·´Ó¦£¬½Ï¶Ìʱ¼äÄÚ¾ù¿É×ÔÐкÃת¡£ÓÉÓÚ°ÂÇúëÄ¿ÉÄÜÒýÆðѪÌǵ÷½ÚÎÉÂÒ£¬Ó¦¼à²âѪÌÇˮƽ£¬ÒÔÃâ·¢Éú²»Á¼ºó¹û[15]¡£±¾Ñо¿ÖÐδ·¢ÏÖADR£¬Ìáʾ°ÂÇúëÄÁÙ´²Ó¦Óð²È«ÐԽϺá£

¡¡¡¡3.5 ¡¢Ð¡½á

¡¡¡¡¸ÃÔº°ÂÇúëÄÁÙ´²Ó¦Óûù±¾ºÏÀí£¬µ«³¬ËµÃ÷ÊéÏÖÏó¶à·¢¡£³¬ËµÃ÷ÊéÓÃÒ©²¢·Ç²»ºÏÀíÓÃÒ©£¬Ò½ÁÆ»ú¹¹Ó¦Öƶ©ÓëÒ½ÁÆÐÐΪÏàÊÊÓ¦µÄ³¬ËµÃ÷ÊéÓÃÒ©¹ÜÀí¹æ¶¨£¬¹æ·¶³¬ËµÃ÷ÊéÓÃÒ©ÐÐΪ¡£½¨Ò鿪չÊÊÓ¦Ö¤Ò©ÎïÁÙ´²Ñо¿£¬ºÏÀí¡¢ºÏ¹æÍØÕ¹Ò©ÎïÊÊÓ¦Ö¤£¬ÒÔ±£Ö¤»¼ÕßÓÃÒ©°²È«¡¢ÓÐЧ¡¢¾­¼Ã¡£

¡¡¡¡²Î¿¼ÎÄÏ×

¡¡¡¡[1]³ÂÐÂÇ«£¬ ½ðÓÐÔ¥,ÌÀ¹â.³ÂÐÂǫбàÒ©Îïѧ(µÚ18°æ)M] .±±¾©:ÈËÃñÎÀÉú³ö°æÉç, 2018:608- 609.

¡¡¡¡[2]ÖÜÈÙ±ó£¬ÁÖÁØ. ¼±ÐÔÉÏÏû»¯µÀ³öѪ¼±ÕïÕïÖÎÁ÷³Ìר¼Ò¹²Ê¶(ÐÞ¶©¸å)µÄ²ûÊÍ[] .ÖйúÈ«¿Æҽѧ, 2015,18(33):4021-4024.

¡¡¡¡[3]Ðì¾ü,´÷¼ÑÔ­,Òü·.¼±ÐÔÉÏÏû»¯µÀ³öѪ¼±ÕïÕïÖÎÁ÷³Ìר¼Ò¹²Ê¶[J] .Öйú¼±¾Èҽѧ£¬2021.41(1):1-10.

¡¡¡¡[4]ÌÀÃúêÅ,¸êÖ®ï£.²»Ã÷Ô­ÒòÏû»¯µÀ³öѪµÄ´¦Àí½øÕ¹ºÍÌôÕ½[J] .賦²¡Ñ§, 2018,23(8):449-454.

¡¡¡¡[5]¶ÅÞÈÆæ,³ÂÆä¿ü,Àîºê×Ö,µÈ.Öйú¼±ÐÔÒÈÏÙÑ×ÕïÖÎÖ¸ÄÏ(2019Äê,ÉòÑô)[J .ÁÙ´²¸Îµ¨²¡ÔÓÖ¾, 2019,35(12):2706-2711.

¡¡¡¡[6]Áõ°î¹ú,ÀîÃ÷´º,¸¶ËÉÁÖ.°ÂÇúëĸ¨ÖúÖÎÁƼ±ÐÔÒÈÏÙÑ×ÁÙ´²Ð§¹û¶Ô±È¹Û²ì[J] .ÈËÃñ¾üÒ½, 2020,63(4):375-378.

¡¡¡¡[7]»Æ½¨¹â.°ÂÇúëÄÖÎÁÆÇáÖ¢¼±ÐÔÒÈÏÙÑ×µÄÁÙ´²ÁÆЧ[J] .ÁÙ´²ºÏÀíÓÃÒ©ÔÓÖ¾£¬2020, 13(28):26-27.

¡¡¡¡[8]Ðí¼Ñ࣬Áº±ûǬ,¹ù½¨.°ÂÇúëÄÁªºÏ³£¹æÖÎÁÆÓÃÓÚ»º½â¶ñÐÔ³¦¹£×èÓÐЧÐÔÓ밲ȫÐÔµÄMeta·ÖÎö[J].ÖйúÒ©·¿£¬ 2019,30(22):3138-3143.

¡¡¡¡[9]ÍõΡ,Çñ·ã,ÌÆÁú.´×Ëá°ÂÇúëÄÁªºÏ°ÂɳÀû²¬ÖÎÁÆÕ³Á¬ÐÔ³¦¹£×èÁÙ´²Ð§¹û¹Û²ì[J] .ÁÙ´²¾üÒ½ÔÓÖ¾, 2020.48(4)44-443.

¡¡¡¡[10]¶¡ÓÀ»Ô.°ÂÇúëÄÖÎÁƳ¦¹£×è50ÀýJ] .ÖйúÒ©Òµ, 2012,21(21)-:107-108.

¡¡¡¡[11]³Â¾²·æ,³Âº£Ñà¡£ ³ÂÑ©ÑµÈ.°ÂÇúëIJ»Í¬¸øÒ©·½Ê½ÖÎÁƼ±ÐÔÒÈÏÙÑ×ÁÙ´²Ð§¹ûMeta·ÖÎö[J].°²»ÕÒ½Ò© , 2020 ,24(2):402-408.

¡¡¡¡[12]Íõ¿ü,÷Üç.°ÂÇúëÄÔÚÆÕÍâ¿ÆµÄÁÙ´²Ó¦Óü°½øÕ¹[J] .ÐÄѪ¹ÜÍâ¿ÆÔÓÖ¾µç×Ó°æ, 2018,7(1):191.

¡¡¡¡[13]ºú¹ðÓ¢,Óౣƽ. °ÂÇúëÄÁªºÏÖÊ×Ó±ÃÒÖÖƼÁÖÎÁƷǾ²ÂöÇúÕÅÐÔÉÏÏû»¯µÀ³öѪµÄMeta·ÖÎö[J] .賦²¡Ñ§ºÍ¸Î²¡Ñ§ÔÓÖ¾£¬2015,24(12): 1479-1484.

¡¡¡¡[14]ÔøΪ³Û.°ÂÃÀÀ­ßòÁªºÏ°ÂÇúëÄÖÎÁƸÎÓ²»¯ÉÏÏû»¯µÀ³öѪµÄЧ¹ûÓ밲ȫÐÔÓÅÊÆ·ÖÎö[J] .¼ªÁÖҽѧ£¬ 2021,42(1):135-137.

¡¡¡¡[15]ÍõÄÈ£¬Íõº£ÌΣ¬ÑîöÎ.°ÂÇúëÄËùÖµÍѪÌÇ·çÏյĻعËÐÔÑо¿[J] . ʵÓÃÒ©ÎïÓëÁÙ´², 2021,24(1):82-84.


×÷Õßµ¥Î»£º°²»ÕÒ½¿Æ´óѧ¸½Êô°²ÇìҽԺҩʹÜÀí¿Æ
Ô­Îijö´¦£º³ÌÍôÇÚ.ijԺ°ÂÇúëÄÁÙ´²Ó¦ÓúÏÀíÐÔ·ÖÎö[J].ÖйúÒ©Òµ,2021,30(15):125-127.
Ïà¹ØÄÚÈÝÍƼö
Ïà¹Ø±êÇ©£º
·µ»Ø£ºÒ©ÀíѧÂÛÎÄ